Modelling using treatment policy estimands, which are affected by the confounding effects of additional diabetes medications (both from the cost and efficacy perspective), favours treatments where patients receive rescue medication at greater rates and reduces the likelihood of semaglutides cost-effectiveness
doi: 10.2337/db18-0729, 67 HristakevaS.LiaukonyteJ.FelerL
Whilst there is no evidence that Wegovy directly affects mood, significant weight loss and lifestyle changes can impact mental wellbeingboth positively and negatively
* Correspondence: Roberto Codella, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A complete metabolic panel, lipid profile, and EKG may be warranted in older patients or those with comorbidities
To view digital features for this article go to Introduction Type 2 diabetes (T2D) is a progressive, chronic, metabolic disease characterised by persistent hyperglycaemia which, if left untreated, is associated with increased risk of long-term microvascular and macrovascular complications [1]